T. Rowe Price Associates
ALAB icon

T. Rowe Price Associates’s Astera Labs ALAB Stock Holding History

T. Rowe Price Associates’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16B Buy
2,409,693
+1,791,194
+290% +$475M 0.12% 148
2026
Q1 		$67.8M Sell
618,499
-545,915
-47% -$77.8M 0.01% 703
2025
Q4 		$194M Buy
1,164,414
+720,844
+163% +$121M 0.02% 474
2025
Q3 		$86.9M Buy
443,570
+386,161
+673% +$63.5M 0.01% 654
2025
Q2 		$5.19M Buy
57,409
+14,270
+33% +$1.13M ﹤0.01% 1259
2025
Q1 		$2.58M Sell
43,139
-179,780
-81% -$16.6M ﹤0.01% 1499
2024
Q4 		$29.5M Buy
222,919
+208,971
+1,498% +$19.6M ﹤0.01% 896
2024
Q3 		$731K Sell
13,948
-200,538
-93% -$9.41M ﹤0.01% 2096
2024
Q2 		$13M Sell
214,486
-385,514
-64% -$26.7M ﹤0.01% 1057
2024
Q1 		$44.5M Buy
+600,000
New +$44.5M 0.01% 762

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates's ALAB Position: Q2 2026 in Review

T. Rowe Price Associates increased its Astera Labs (ALAB) stake by 290% in Q2 2026, buying an estimated $475M and bringing the position to 2,409,693 shares worth $1.16B. The position accounts for 0.12% of the portfolio, ranked #148.

T. Rowe Price Associates first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • T. Rowe Price Associates held 2,409,693 shares of Astera Labs worth $1.16B as of Q2 2026.
  • T. Rowe Price Associates bought 1,791,194 Astera Labs shares in Q2 2026, an estimated $475M.
  • Astera Labs made up 0.12% of T. Rowe Price Associates's portfolio in Q2 2026, its #148 holding.
  • T. Rowe Price Associates first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.